The Board of Directors of Shanghai Aladdin Biochemical Technology Co.,Ltd. has authorized a buyback plan on June 7, 2024.
Shanghai Aladdin Biochemical Technology Co.,Ltd.
Equities
688179
CNE100005XD0
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.91 CNY | +3.12% |
|
-3.13% | -27.59% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-27.59% | 378M | |
+23.13% | 46.93B | |
+37.49% | 39.08B | |
-8.73% | 38.48B | |
+28.09% | 31.01B | |
-12.26% | 26.14B | |
+10.57% | 25.88B | |
+45.05% | 14.15B | |
+32.23% | 12.53B | |
-6.56% | 11.36B |
- Stock Market
- Equities
- 688179 Stock
- News Shanghai Aladdin Biochemical Technology Co.,Ltd.
- Shanghai Aladdin Biochemical Technology Co.,Ltd. authorizes a Buyback Plan.